Vasomune Therapeutics Overview

  • Founded
  • 2012
  • Status
  • Private
  • Employees
  • 7
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $2.79M
Latest Deal Amount
  • Investors
  • 4

Vasomune Therapeutics General Information


Developer of biotechnology platform intended to help with the treatment of target diseases associated with vascular dysfunction and destabilization. The company's drug candidate targets a signaling molecule in the vasculature responsible for regulating barrier defense and the host vascular response to injury enabling doctors to help patients to fight against illness by modifying the cellular response to disease.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 180 John Street
  • Suite 305
  • Toronto, Ontario M5T 1X5
  • Canada
+1 (647) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vasomune Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 18-Aug-2020 $2.79M 00.00 Completed Generating Revenue
1. Seed Round 20-Oct-2014 00.00 00.00 Completed Generating Revenue
To view Vasomune Therapeutics’s complete valuation and funding history, request access »

Vasomune Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Douglas Hamilton Chief Executive Officer & President
Steven Chackowicz Executive
Parimal Nathwani Chairman
You’re viewing 3 of 6 executive team members. Get the full list »

Vasomune Therapeutics Board Members (6)

Name Representing Role Since
Meenu Chhabra Self Board Member 000 0000
Michael Young Self Board Member 000 0000
Niclas Stiernholm Ph.D Self Board Member 000 0000
Parimal Nathwani Self Chairman 000 0000
You’re viewing 4 of 6 board members. Get the full list »

Vasomune Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Vasomune Therapeutics Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Ontario Bioscience Innovation Organization Not-For-Profit Venture Capital 000 0000 000000 0
United States Department of Defense Government 000 0000 000000 0
Ontario Genomics Corporation Minority 000 0000 000000 0
Toronto Innovation Acceleration Partners Not-For-Profit Venture Capital Minority 000 0000 000000 0
To view Vasomune Therapeutics’s complete investors history, request access »